Xiyanping allergic reaction, most commonly erythema and pruritus around the injection site, but more rarely anaphylactic reactions may occur, which can be life-threatening. Also, andrographolide and related derivatives are known to be abortifacient, making xiyanping unsuitable for use in pregnant women. Xiyanping Xiyanping (喜炎平) is an anti-inflammatory and antiviral preparation developed and licensed for use in China. It is a semi-synthetic injectable product derived from the active component of the plant "Andrographis paniculata" (Chuan Xin Lian, 穿心蓮), which is used in Traditional Chinese medicine. Xiyanping is primarily composed of 9-dehydro-17-hydro-andrographolide and sodium 9-dehydro-17-hydro-andrographolide-19-yl sulfate. It is used mainly in the treatment
Allergic transfusion reaction from a donor who has allergies, followed by antigen exposure. An allergic transfusion reaction is a type of transfusion reaction that is defined according to the Center for Disease Control (CDC) as: An allergic transfusion reaction is diagnosed if two or more of the following occur within 4 hours of cessation of transfusion: A probable diagnosis results if any one of the following occurring within 4 hours of cessation of transfusion: Treatment of an allergic transfusion reaction is to immediate stop the transfusion. If the only symptoms are mild (i.e., hives and itching), the patient may be treated with an